Abstract

Hematologic malignancies, a diverse and intricate array of diseases affecting the blood and bone marrow, present distinctive hurdles for patients and their families, particularly concerning end-of-life arrangements. As the realm of palliative care advances, the optimal timing and seamless integration of palliative measures have taken center stage in augmenting the life quality of patients grappling with hematologic malignancies in their final phases. This piece delves into the ramifications of initiating palliative care at an early juncture on outcomes during the terminal stages for individuals afflicted with hematologic malignancies. By meticulously examining existing literature, the article underscores the advantages, obstacles, and potential methodologies for embedding early palliative care interventions within this specific demographic.